Thrombin-Induced CCAAT/Enhancer-Binding Protein β Activation and IL-8/CXCL8 Expression via MEKK1, ERK, and p90 Ribosomal S6 Kinase 1 in Lung Epithelial Cells

被引：20

作者：

Lin, Chien-Huang ^{[1
]}

Nai, Po-Ling ^{[1
]}

Bien, Mauo-Ying ^{[2
,3
]}

Yu, Chung-Chi ^{[1
]}

Chen, Bing-Chang ^{[2
]}

机构：

[1] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei 110, Taiwan

[2] Taipei Med Univ, Sch Resp Therapy, Coll Med, Taipei 110, Taiwan

[3] Taipei Med Univ Hosp, Dept Internal Med, Taipei 110, Taiwan

来源：

JOURNAL OF IMMUNOLOGY | 2014年 / 192卷 / 01期

关键词：

NF-KAPPA-B; GENE-EXPRESSION; STATUS-ASTHMATICUS; INTERLEUKIN-8; IL-8; RECEPTORS; PHOSPHORYLATION; TRANSACTIVATION; MACROPHAGES; PATHWAYS;

D O I：

10.4049/jimmunol.1203323

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Thrombin, a serine protease, is a well-known coagulation factor generated during vascular injury and plays an important role in lung inflammation. We previously showed that the c-Src- and Rac/PI3K/Akt-dependent NF-kappa B pathways are involved in thrombin-induced IL-8/CXCL8 expression in human lung epithelial cells (A549). In this study, we investigated the role of the MEK kinase (MEKK)1/ERK/p90 ribosomal S6 kinase (RSK)1-dependent C/EBP beta signaling pathway in thrombin-induced IL-8/CXCL8 expression. Thrombin-induced IL-8/CXCL8 release and IL-8/CXCL8-luciferase activity were attenuated by small interfering RNA (siRNA) of C/EBP beta and by cells transfected with the C/EBP beta site mutation of the IL-8/CXCL8 construct. Moreover, thrombin-induced kappa B-luciferase activity was also inhibited by C/EBP beta siRNA. The thrombin-induced increases in IL-8/CXCL8 release and IL-8/CXCL8-luciferase were also inhibited by MEKK1 siRNA, PD98059 (an MEK inhibitor), U0126 (an ERK inhibitor), and RSK1 siRNA. Treatment of cells with thrombin caused an increase in C/EBP beta phosphorylation at Thr(235), C/EBP beta-luciferase activity, recruitment of C/EBP beta to the IL-8/CXCL8 promoter, and C/EBP beta-specific DNA complex formation. Furthermore, thrombin-mediated C/EBP beta phosphorylation and C/EBP beta-luciferase activity were inhibited by MEKK1 siRNA, PD98059, and RSK1 siRNA. Stimulation of cells with thrombin resulted in an increase in RSK1 phosphorylation at Thr(359)/Ser(363), and this effect was inhibited by MEKK1 siRNA and PD98059. The thrombin-induced increase in ERK activation was inhibited by MEKK1 siRNA. These results imply that thrombin activates the MEKK1/ERK/RSK1 signaling pathway, which in turn initiates C/EBP beta activation, recruitment of C/EBP beta to the IL-8/CXCL8 promoter, and C/EBP beta-specific DNA complex formation, and ultimately induces IL-8/CXCL8 expression and release in lung epithelial cells.

引用

页码：338 / 348

页数：11

共 31 条

[21] The p38 mitogen-activated protein kinase regulates interleukin-1β-induced IL-8 expression via an effect on the IL-8 promoter in intestinal epithelial cells
Parhar, K
Ray, A
Steinbrecher, U
Nelson, C
Salh, B
IMMUNOLOGY, 2003, 108 (04) : 502 - 512
[22] Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells
Kim, Sunghoon
Kim, Jihyun
Kim, Bonglee
Kim, Junghyo
CLINICAL CANCER RESEARCH, 2013, 19
[23] Melatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells
Kim, Ji-Hyun
Jeong, Soo-Jin
Kim, Bonglee
Yun, Sun-Mi
Choi, Do Young
Kim, Sung-Hoon
JOURNAL OF PINEAL RESEARCH, 2012, 52 (02) : 244 - 252
[24] Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Stratford, Anna L.
Fry, Christopher J.
Desilets, Curtis
Davies, Alastair H.
Cho, Yong Y.
Li, Yvonne
Dong, Zigang
Berquin, Isabelle M.
Roux, Philippe P.
Dunn, Sandra E.
BREAST CANCER RESEARCH, 2008, 10 (06):
[25] Expression of S100A8 is induced by interleukin-1α in TR146 epithelial cells through a mechanism involving CCAAT/enhancer binding protein β
Qin, Mingqun
Zou, Yantao
Zhong, Kanghua
Guo, Yong
Zou, Xianqiong
MOLECULAR MEDICINE REPORTS, 2019, 19 (03) : 2413 - 2420
[26] Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells
Anna L Stratford
Christopher J Fry
Curtis Desilets
Alastair H Davies
Yong Y Cho
Yvonne Li
Zigang Dong
Isabelle M Berquin
Philippe P Roux
Sandra E Dunn
Breast Cancer Research, 10
[27] Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)
Reipas, Kristen M.
Law, Jennifer H.
Couto, Nicole
Islam, Sumaiya
Li, Yvonne
Li, Huifang
Cherkasov, Artem
Jung, Karen
Cheema, Amarpal S.
Jones, Steven J. M.
Hassell, John A.
Dunn, Sandra E.
ONCOTARGET, 2013, 4 (02) : 329 - 345
[28] Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers
Stratford, Anna L.
Reipas, Kristen
Hu, Kaiji
Fotovati, Abbas
Brough, Rachel
Frankum, Jessica
Takhar, Mandeep
Watson, Peter
Ashworth, Alan
Lord, Christopher J.
Lasham, Annette
Print, Cristin G.
Dunn, Sandra E.
STEM CELLS, 2012, 30 (07) : 1338 - 1348
[29] ERK1/2 and NFid3 are key signaling pathways in the regulation of CXCL8 expression and secretion by intestinal epithelial cells in response to P2Y6 receptor activation
Grbic, Djordje M.
Gendron, Fernand-Pierre
JOURNAL OF IMMUNOLOGY, 2009, 182
[30] Disruption of P90 Ribosomal S6 Kinase Binding 3 to Muscle A-kinase Anchoring Protein In Vivo Via Adeno-associated Virus Expression of a Competing Peptide Attenuates Pressure Overload-induced Cardiac Hypertrophy
Passariello, Catherine L.
Kritzer, Michael D.
Thakur, Hrishikesh
Sanders, Michael
Li Jinliang
Kapiloff, Michael S.
CIRCULATION RESEARCH, 2014, 115

← 1 2 3 4 →